Please Scroll Down to See Forums Below
Letrozole
- Thread starter John Juan
- Start date
John Juan
New member
How is your quad muscularity coming in from the letrozole?
John Juan
New member
Posted in another forum....
"Letro will be the most powerful AI you can use, it will inhibit 98+% of estrogen using a dose as low as .25mg and even lower. This is why I suggest you do not use a dose higher than .50mg while on cycle just trying to prevent estrogen related side effects ."
"Letro will be the most powerful AI you can use, it will inhibit 98+% of estrogen using a dose as low as .25mg and even lower. This is why I suggest you do not use a dose higher than .50mg while on cycle just trying to prevent estrogen related side effects ."
Elvia1023
New member
As you know I train my legs harder than anything but it is a struggle due to genetics and my height. But since the letro (and peps) the vascularity is really coming out in my quads. The muscle looks harder and just better overall. Looking forward to training them next.
I started 1.5mg last night... so strong... could feel the difference when I woke up.
John Juan
New member
The effect of aromatase inhibitor letrozole incorporated in gonadotrophin-releasing hormone antagonist multiple dose protocol in poor responders undergoing in vitro fertilization.
AuthorsLee KH, et al. Show all Journal
Obstet Gynecol Sci. 2014 May;57(3):216-22. doi: 10.5468/ogs.2014.57.3.216. Epub 2014 May 15.
Affiliation
Abstract
OBJECTIVE: To evaluate whether letrozole incorporated in a gonadotrophin-releasing hormone (GnRH) antagonist multiple dose protocol (MDP) improved controlled ovarian stimulation (COS) and in vitro fertilization (IVF) results in poor responders who underwent IVF treatment.
METHODS: In this retrospective cohort study, a total of 103 consecutive IVF cycles that were performed during either the letrozole/GnRH antagonist MDP cycles (letrozole group, n=46) or the standard GnRH antagonist MDP cycles (control group, n=57) were included in 103 poor responders. COS results and IVF outcomes were compared between the two groups.
RESULTS: Total dose and days of recombinant human follicle stimulating hormone (rhFSH) administered were significantly fewer in the letrozole group than in the control group. Duration of GnRH antagonist administered was also shorter in the letrozole group. The number of oocytes retrieved was significantly higher in the letrozole group. However, clinical pregnancy rate per cycle initiated, clinical pregnancy rate per embryo transfer, embryo implantation rate and miscarriage rate were similar in the two groups.
CONCLUSION: The letrozole incorporated in GnRH antagonist MDP may be more effective because it results comparable pregnancy outcomes with shorter duration and smaller dose of rhFSH, when compared with the standard GnRH antagonist MDP.
AuthorsLee KH, et al. Show all Journal
Obstet Gynecol Sci. 2014 May;57(3):216-22. doi: 10.5468/ogs.2014.57.3.216. Epub 2014 May 15.
Affiliation
Abstract
OBJECTIVE: To evaluate whether letrozole incorporated in a gonadotrophin-releasing hormone (GnRH) antagonist multiple dose protocol (MDP) improved controlled ovarian stimulation (COS) and in vitro fertilization (IVF) results in poor responders who underwent IVF treatment.
METHODS: In this retrospective cohort study, a total of 103 consecutive IVF cycles that were performed during either the letrozole/GnRH antagonist MDP cycles (letrozole group, n=46) or the standard GnRH antagonist MDP cycles (control group, n=57) were included in 103 poor responders. COS results and IVF outcomes were compared between the two groups.
RESULTS: Total dose and days of recombinant human follicle stimulating hormone (rhFSH) administered were significantly fewer in the letrozole group than in the control group. Duration of GnRH antagonist administered was also shorter in the letrozole group. The number of oocytes retrieved was significantly higher in the letrozole group. However, clinical pregnancy rate per cycle initiated, clinical pregnancy rate per embryo transfer, embryo implantation rate and miscarriage rate were similar in the two groups.
CONCLUSION: The letrozole incorporated in GnRH antagonist MDP may be more effective because it results comparable pregnancy outcomes with shorter duration and smaller dose of rhFSH, when compared with the standard GnRH antagonist MDP.
John Juan
New member
That's hardcore!!!
Elvia1023
New member
It doesn't help matters though that I seem to have developed an addiction to vanilla ice cream with honey on top... 5 days in a row I have had lots... had about 1000 cals worth before
John Juan
New member
It doesn't help matters though that I seem to have developed an addiction to vanilla ice cream with honey on top... 5 days in a row I have had lots... had about 1000 cals worth before
Man, I want some of that. I trained legs two hours ago and now I'm getting real hungry!!!
